On 2025-08-12, Passage Bio, Inc. (PASG) announced earnings per share of $-2.96 for the fiscal quarter ending 2025-06-30, beating the average analyst estimate of $-4.00.
The next expected annoucement date for quarterly earnings is 2025-11-12, with an average estimated earnings per share of $-2.64 for the fiscal quarter ending 2025-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-08-12 | 2025-06-30 | $-4.00 | $-2.96 |
| 2025-05-13 | 2025-03-31 | $-4.80 | $-5.00 |
| 2025-03-04 | 2024-12-31 | $-4.20 | $-4.00 |
| 2024-11-13 | 2024-09-30 | $-4.60 | $-6.20 |
| 2024-08-08 | 2024-06-30 | $-6.20 | $-5.20 |
| 2024-05-14 | 2024-03-31 | $-7.40 | $-6.00 |
| 2024-03-04 | 2023-12-31 | $-8.20 | $-6.00 |
| 2023-11-13 | 2023-09-30 | $-9.40 | $-9.80 |
| 2023-08-07 | 2023-06-30 | $-9.60 | $-8.80 |
| 2023-05-11 | 2023-03-31 | $-9.80 | $-12.60 |
| 2023-03-06 | 2022-12-31 | $-9.60 | $-10.00 |
| 2022-11-10 | 2022-09-30 | $-15.00 | $-9.80 |
| 2022-08-04 | 2022-06-30 | $-15.60 | $-14.60 |
| 2022-05-16 | 2022-03-31 | $-17.60 | $-15.80 |
| 2022-03-03 | 2021-12-31 | $-16.80 | $-18.60 |
| 2021-11-04 | 2021-09-30 | $-16.00 | $-15.40 |
| 2021-08-05 | 2021-06-30 | $-14.60 | $-18.00 |
| 2021-05-05 | 2021-03-31 | $-13.20 | $-15.20 |
| 2021-03-03 | 2020-12-31 | $-13.80 | $-17.00 |
| 2020-11-10 | 2020-09-30 | $-14.60 | $-12.60 |
| 2020-08-13 | 2020-06-30 | $-12.00 | $-12.00 |
| 2020-05-11 | 2020-03-31 | $-9.20 | $-20.00 |